06-03-2021 09:12 AM | Source: Reuters
India government seals deal for 300 million Biological-E COVID-19 vaccine doses
BENGALURU - India's government said on Thursday it has inked a deal with domestic vaccine maker Biological-E for 300 million COVID-19 vaccine doses for 15 billion rupees ($205.62 million).
The vaccine, which is currently undergoing phase-3 clinical trials, will likely to be available in the next few months, the health ministry said in a statement.
Latest News
Elon Musk invites billionaire investor Warren Buffet...
Crude Oil is correcting after strong up rally and pe...
Rallis India gains on commissioning new automated 80...
MCX Gold is likely to trade with sideways to negativ...
Tata Steel gains after its arm inks MoU with Hygenco
Mahindra Finance declines on reporting marginal fall...
RBI proposes tighter rules to govern lending to proj...
MCX Gold June is expected to find the floor near 701...
Amber Enterprises shines on acquiring 50% stake in R...
Prospect Commodities touches roof on inking MoU with...